Global and Region Extracorporeal Membrane Oxygenation (ECMO) Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Extracorporeal Membrane Oxygenation (ECMO) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Extracorporeal Membrane Oxygenation (ECMO)market, defines the market attractiveness level of Extracorporeal Membrane Oxygenation (ECMO) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Extracorporeal Membrane Oxygenation (ECMO) industry, describes the types of Extracorporeal Membrane Oxygenation (ECMO) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Extracorporeal Membrane Oxygenation (ECMO) market and the development prospects and opportunities of Extracorporeal Membrane Oxygenation (ECMO) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Extracorporeal Membrane Oxygenation (ECMO) market in Chapter 13.

    By Player:

    • Getinge Group (Sweden)

    • EUROSETS plc (Ireland)

    • LivaNova PLC (UK)

    • XENIOS AG (Germany)

    • Terumo Corporation (Japan)

    • MicroPort Scientific Corporation (China)

    • NIPRO Corporation (Japan)

    • OriGen Biomedical, Inc (US)

    • ALung Technologies, Inc (Germany)

    • Medtronic Srl (Italy)

    By Type:

    • Venovenous Extracorporeal Membrane Oxygenation

    • Venoarterial Extracorporeal Membrane Oxygenation

    • Arteriovenous Extracorporeal Membrane Oxygenation

    By End-User:

    • Congenital Diaphragmatic Hernia (CDH)

    • Birth Defects of the Heart

    • Meconium Aspiration Syndrome (MAS)

    • Severe Pneumonia

    • Severe Air Leak Problems

    • Severe High Blood Pressure in the Arteries of the Lungs (PPHN)

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Extracorporeal Membrane Oxygenation (ECMO) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Extracorporeal Membrane Oxygenation (ECMO) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Extracorporeal Membrane Oxygenation (ECMO) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Extracorporeal Membrane Oxygenation (ECMO) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Extracorporeal Membrane Oxygenation (ECMO) Market Analysis and Outlook to 2022

    • 7.1 Global Extracorporeal Membrane Oxygenation (ECMO) Consumption (2017-2022)

    • 7.2 United States Extracorporeal Membrane Oxygenation (ECMO) Consumption (2017-2022)

    • 7.3 Europe Extracorporeal Membrane Oxygenation (ECMO) Consumption (2017-2022)

    • 7.4 China Extracorporeal Membrane Oxygenation (ECMO) Consumption (2017-2022)

    • 7.5 Japan Extracorporeal Membrane Oxygenation (ECMO) Consumption (2017-2022)

    • 7.6 India Extracorporeal Membrane Oxygenation (ECMO) Consumption (2017-2022)

    • 7.7 South Korea Extracorporeal Membrane Oxygenation (ECMO) Consumption (2017-2022)

    8 Region and Country-wise Extracorporeal Membrane Oxygenation (ECMO) Market Analysis and Outlook to 2028

    • 8.1 Global Extracorporeal Membrane Oxygenation (ECMO) Consumption Forecast (2022-2028)

    • 8.2 United States Extracorporeal Membrane Oxygenation (ECMO) Consumption Forecast (2022-2028)

    • 8.3 Europe Extracorporeal Membrane Oxygenation (ECMO) Consumption Forecast (2022-2028)

    • 8.4 China Extracorporeal Membrane Oxygenation (ECMO) Consumption Forecast (2022-2028)

    • 8.5 Japan Extracorporeal Membrane Oxygenation (ECMO) Consumption Forecast (2022-2028)

    • 8.6 India Extracorporeal Membrane Oxygenation (ECMO) Consumption Forecast (2022-2028)

    • 8.7 South Korea Extracorporeal Membrane Oxygenation (ECMO) Consumption Forecast (2022-2028)

    9 Global Extracorporeal Membrane Oxygenation (ECMO) Market Outlook by Types and Applications to 2022

    • 9.1 Global Extracorporeal Membrane Oxygenation (ECMO) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Venovenous Extracorporeal Membrane Oxygenation Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Venoarterial Extracorporeal Membrane Oxygenation Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Arteriovenous Extracorporeal Membrane Oxygenation Consumption and Growth Rate (2017-2022)

    • 9.2 Global Extracorporeal Membrane Oxygenation (ECMO) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Congenital Diaphragmatic Hernia (CDH) Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Birth Defects of the Heart Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Meconium Aspiration Syndrome (MAS) Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Severe Pneumonia Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Severe Air Leak Problems Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Severe High Blood Pressure in the Arteries of the Lungs (PPHN) Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Extracorporeal Membrane Oxygenation (ECMO) Market Outlook by Types and Applications to 2028

    • 10.1 Global Extracorporeal Membrane Oxygenation (ECMO) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Venovenous Extracorporeal Membrane Oxygenation Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Venoarterial Extracorporeal Membrane Oxygenation Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Arteriovenous Extracorporeal Membrane Oxygenation Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Extracorporeal Membrane Oxygenation (ECMO) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Congenital Diaphragmatic Hernia (CDH) Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Birth Defects of the Heart Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Meconium Aspiration Syndrome (MAS) Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Severe Pneumonia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Severe Air Leak Problems Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Severe High Blood Pressure in the Arteries of the Lungs (PPHN) Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Extracorporeal Membrane Oxygenation (ECMO) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Extracorporeal Membrane Oxygenation (ECMO) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Extracorporeal Membrane Oxygenation (ECMO) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Extracorporeal Membrane Oxygenation (ECMO) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Extracorporeal Membrane Oxygenation (ECMO) Market Competitive Analysis

    • 14.1 Getinge Group (Sweden)

      • 14.1.1 Getinge Group (Sweden) Company Details

      • 14.1.2 Getinge Group (Sweden) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Getinge Group (Sweden) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    • 14.2 EUROSETS plc (Ireland)

      • 14.2.1 EUROSETS plc (Ireland) Company Details

      • 14.2.2 EUROSETS plc (Ireland) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 EUROSETS plc (Ireland) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    • 14.3 LivaNova PLC (UK)

      • 14.3.1 LivaNova PLC (UK) Company Details

      • 14.3.2 LivaNova PLC (UK) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 LivaNova PLC (UK) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    • 14.4 XENIOS AG (Germany)

      • 14.4.1 XENIOS AG (Germany) Company Details

      • 14.4.2 XENIOS AG (Germany) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 XENIOS AG (Germany) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    • 14.5 Terumo Corporation (Japan)

      • 14.5.1 Terumo Corporation (Japan) Company Details

      • 14.5.2 Terumo Corporation (Japan) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Terumo Corporation (Japan) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    • 14.6 MicroPort Scientific Corporation (China)

      • 14.6.1 MicroPort Scientific Corporation (China) Company Details

      • 14.6.2 MicroPort Scientific Corporation (China) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 MicroPort Scientific Corporation (China) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    • 14.7 NIPRO Corporation (Japan)

      • 14.7.1 NIPRO Corporation (Japan) Company Details

      • 14.7.2 NIPRO Corporation (Japan) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 NIPRO Corporation (Japan) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    • 14.8 OriGen Biomedical, Inc (US)

      • 14.8.1 OriGen Biomedical, Inc (US) Company Details

      • 14.8.2 OriGen Biomedical, Inc (US) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 OriGen Biomedical, Inc (US) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    • 14.9 ALung Technologies, Inc (Germany)

      • 14.9.1 ALung Technologies, Inc (Germany) Company Details

      • 14.9.2 ALung Technologies, Inc (Germany) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 ALung Technologies, Inc (Germany) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    • 14.10 Medtronic Srl (Italy)

      • 14.10.1 Medtronic Srl (Italy) Company Details

      • 14.10.2 Medtronic Srl (Italy) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Medtronic Srl (Italy) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Extracorporeal Membrane Oxygenation (ECMO)

    • Figure Extracorporeal Membrane Oxygenation (ECMO) Picture

    • Table Global Extracorporeal Membrane Oxygenation (ECMO) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Extracorporeal Membrane Oxygenation (ECMO) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Extracorporeal Membrane Oxygenation (ECMO) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Extracorporeal Membrane Oxygenation (ECMO) Consumption by Country (2017-2022)

    • Figure United States Extracorporeal Membrane Oxygenation (ECMO) Consumption and Growth Rate (2017-2022)

    • Table Europe Extracorporeal Membrane Oxygenation (ECMO) Consumption and Growth Rate (2017-2022)

    • Figure China Extracorporeal Membrane Oxygenation (ECMO) Consumption and Growth Rate (2017-2022)

    • Figure Japan Extracorporeal Membrane Oxygenation (ECMO) Consumption and Growth Rate (2017-2022)

    • Figure India Extracorporeal Membrane Oxygenation (ECMO) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Extracorporeal Membrane Oxygenation (ECMO) Consumption and Growth Rate (2017-2022)

    • Figure Global Extracorporeal Membrane Oxygenation (ECMO) Consumption Forecast by Country (2022-2028)

    • Figure United States Extracorporeal Membrane Oxygenation (ECMO) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Extracorporeal Membrane Oxygenation (ECMO) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Extracorporeal Membrane Oxygenation (ECMO) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Extracorporeal Membrane Oxygenation (ECMO) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Extracorporeal Membrane Oxygenation (ECMO) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Extracorporeal Membrane Oxygenation (ECMO) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Venovenous Extracorporeal Membrane Oxygenation Consumption and Growth Rate (2017-2022)

    • Figure Global Venoarterial Extracorporeal Membrane Oxygenation Consumption and Growth Rate (2017-2022)

    • Figure Global Arteriovenous Extracorporeal Membrane Oxygenation Consumption and Growth Rate (2017-2022)

    • Figure Global Congenital Diaphragmatic Hernia (CDH) Consumption and Growth Rate (2017-2022)

    • Figure Global Birth Defects of the Heart Consumption and Growth Rate (2017-2022)

    • Figure Global Meconium Aspiration Syndrome (MAS) Consumption and Growth Rate (2017-2022)

    • Figure Global Severe Pneumonia Consumption and Growth Rate (2017-2022)

    • Figure Global Severe Air Leak Problems Consumption and Growth Rate (2017-2022)

    • Figure Global Severe High Blood Pressure in the Arteries of the Lungs (PPHN) Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Venovenous Extracorporeal Membrane Oxygenation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Venoarterial Extracorporeal Membrane Oxygenation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Arteriovenous Extracorporeal Membrane Oxygenation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Congenital Diaphragmatic Hernia (CDH) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Birth Defects of the Heart Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Meconium Aspiration Syndrome (MAS) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Severe Pneumonia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Severe Air Leak Problems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Severe High Blood Pressure in the Arteries of the Lungs (PPHN) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Extracorporeal Membrane Oxygenation (ECMO) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Extracorporeal Membrane Oxygenation (ECMO) Export by Region (Top 5 Countries) (2017-2028)

    • Table Getinge Group (Sweden) (Foundation Year, Company Profile and etc.)

    • Table Getinge Group (Sweden) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Getinge Group (Sweden) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    • Table EUROSETS plc (Ireland) (Foundation Year, Company Profile and etc.)

    • Table EUROSETS plc (Ireland) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table EUROSETS plc (Ireland) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    • Table LivaNova PLC (UK) (Foundation Year, Company Profile and etc.)

    • Table LivaNova PLC (UK) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table LivaNova PLC (UK) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    • Table XENIOS AG (Germany) (Foundation Year, Company Profile and etc.)

    • Table XENIOS AG (Germany) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table XENIOS AG (Germany) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    • Table Terumo Corporation (Japan) (Foundation Year, Company Profile and etc.)

    • Table Terumo Corporation (Japan) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Terumo Corporation (Japan) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    • Table MicroPort Scientific Corporation (China) (Foundation Year, Company Profile and etc.)

    • Table MicroPort Scientific Corporation (China) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table MicroPort Scientific Corporation (China) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    • Table NIPRO Corporation (Japan) (Foundation Year, Company Profile and etc.)

    • Table NIPRO Corporation (Japan) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table NIPRO Corporation (Japan) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    • Table OriGen Biomedical, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table OriGen Biomedical, Inc (US) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table OriGen Biomedical, Inc (US) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    • Table ALung Technologies, Inc (Germany) (Foundation Year, Company Profile and etc.)

    • Table ALung Technologies, Inc (Germany) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table ALung Technologies, Inc (Germany) Extracorporeal Membrane Oxygenation (ECMO) Product and Service

    • Table Medtronic Srl (Italy) (Foundation Year, Company Profile and etc.)

    • Table Medtronic Srl (Italy) Extracorporeal Membrane Oxygenation (ECMO) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic Srl (Italy) Extracorporeal Membrane Oxygenation (ECMO) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.